158 related articles for article (PubMed ID: 26669974)
1. Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.
Kourelis TV; Buadi FK; Gertz MA; Lacy MQ; Kumar SK; Kapoor P; Go RS; Lust JA; Hayman SR; Rajkumar V; Zeldenrust SR; Russell SJ; Dingli D; Lin Y; Leung N; Hwa YL; Gonsalves W; Kyle RA; Dispenzieri A
Leukemia; 2016 May; 30(5):1079-85. PubMed ID: 26669974
[TBL] [Abstract][Full Text] [Related]
2. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience.
Kourelis TV; Buadi FK; Kumar SK; Gertz MA; Lacy MQ; Dingli D; Go RS; Kapoor P; Lust JA; Hayman SR; Hwa Y; Rajkumar SV; Zeldenrust SR; Russell SJ; Lin Y; Leung N; Kyle RA; Gonsalves WI; Dispenzieri A
Am J Hematol; 2016 Jun; 91(6):585-9. PubMed ID: 26972803
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
[TBL] [Abstract][Full Text] [Related]
5. Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.
Karam C; Klein CJ; Dispenzieri A; Dyck PJ; Mandrekar J; D'Souza A; Mauermann ML
Neurology; 2015 May; 84(19):1981-7. PubMed ID: 25878176
[TBL] [Abstract][Full Text] [Related]
6. POEMS Syndrome: Indian Experience From a Tertiary-Care Institute.
Pramanik R; Sharma A; Sharma A; Gogia A; Sahoo RK; Malik PS; Padma MV; Cyriac SL; Kumar L
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e536-e544. PubMed ID: 31262669
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
Cai QQ; Wang C; Cao XX; Cai H; Zhou DB; Li J
Eur J Haematol; 2015 Oct; 95(4):325-30. PubMed ID: 25401269
[TBL] [Abstract][Full Text] [Related]
8. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
Keddie S; Foldes D; Caimari F; Baldeweg SE; Bomsztyk J; Ziff OJ; Fehmi J; Cerner A; Jaunmuktane Z; Brandner S; Yong K; Manji H; Carr A; Rinaldi S; Reilly MM; D'Sa S; Lunn MP
Neurology; 2020 Jul; 95(3):e268-e279. PubMed ID: 32606227
[TBL] [Abstract][Full Text] [Related]
10. Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome.
Wang C; Huang XF; Cai QQ; Cao XX; Cai H; Zhou D; Li J
Leuk Res; 2016 Nov; 50():78-84. PubMed ID: 27697660
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience.
D'Souza A; Lacy M; Gertz M; Kumar S; Buadi F; Hayman S; Dingli D; Zeldenrust S; Kyle R; Ansell S; Inwards D; Johnston P; Micallef I; Porrata L; Litzow M; Gastineau D; Hogan W; Dispenzieri A
Blood; 2012 Jul; 120(1):56-62. PubMed ID: 22611150
[TBL] [Abstract][Full Text] [Related]
12. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
14. Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome.
Li J; Duan MH; Wang C; Huang XF; Zhang W; Cao XX; Zhu TN; Zhuang JL; Han B; Cai H; Cai HC; Zhou DB
Leukemia; 2017 Jun; 31(6):1375-1381. PubMed ID: 28100909
[TBL] [Abstract][Full Text] [Related]
15. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
Cook G; Iacobelli S; van Biezen A; Ziagkos D; LeBlond V; Abraham J; McQuaker G; Schoenland S; Rambaldi A; Halaburda K; Rovira M; Sica S; Byrne J; Sanz RG; Nagler A; van de Donk NW; Sinisalo M; Cook M; Kröger N; De Witte T; Morris C; Garderet L
Haematologica; 2017 Jan; 102(1):160-167. PubMed ID: 27634201
[TBL] [Abstract][Full Text] [Related]
16. POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases.
Isose S; Misawa S; Kanai K; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Nakaseko C; Kuwabara S
J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):678-80. PubMed ID: 20562460
[TBL] [Abstract][Full Text] [Related]
17. POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience.
Thoennissen GB; Thoennissen NH; Fritz F; Hilbig A; Kerkhoff A; Liersch R; Krug U; Koschmieder S; Müller-Tidow C; Mesters R; Kropff M; Berdel WE
Ann Hematol; 2012 Sep; 91(9):1419-25. PubMed ID: 22543828
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS Syndrome.
Li AA; Gao XM; Zhao H; Shen KN; Zhang L; Cao XX; Li J
Transplant Cell Ther; 2024 Feb; 30(2):207.e1-207.e7. PubMed ID: 37931801
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of patients with POEMS syndrome treated initially with radiation.
Humeniuk MS; Gertz MA; Lacy MQ; Kyle RA; Witzig TE; Kumar SK; Kapoor P; Lust JA; Hayman SR; Buadi FK; Rajkumar SV; Zeldenrust SR; Russell SJ; Dingli D; Lin Y; Leung N; Dispenzieri A
Blood; 2013 Jul; 122(1):68-73. PubMed ID: 23699599
[TBL] [Abstract][Full Text] [Related]
20. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
Miralles GD; O'Fallon JR; Talley NJ
N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
